SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
77.00
Ask:
78.20
Spread: 1.20 (1.558%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

SUPPLEMENTARY PROSPECTUS

13 Sep 2007 14:53

Accsys Technologies PLC13 September 2007 NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION INTO OR IN THE UNITED STATES,AUSTRALIA, CANADA OR JAPAN. 13th September 2007 AIM: AXS PUBLICATION OF SUPPLEMENTARY PROSPECTUS IN CONNECTION WITH THE OFFERING AND EURONEXT LISTING Accsys Technologies PLC (the ''Company'') announces the publication of asupplementary prospectus in connection with the proposed listing of its ordinaryshares on Euronext Amsterdam by NYSE Euronext (the "Euronext Listing") and apublic offering in The Netherlands and private placement to certaininstitutional investors outside The Netherlands of ordinary shares in theCompany (the ''Offering''). An inaccuracy in the Prospectus published by the Company on 3rd September 2007in connection with the Offering and the Euronext Listing (the "Prospectus") hassubsequently become apparent relating to the summary of the UK taxation onchargeable gains for individuals resident in the UK set out in paragraph 15.1 ofPart XI (Additional Information) of the Prospectus. In the opinion of theDirectors of the Company, this may be significant for the purposes of making aninformed assessment of the kind mentioned in sections 87A(2) of the FinancialServices and Markets Act 2000 in relation to the Ordinary Shares in the Company. The Company has therefore today published a supplementary prospectuscorrecting the inaccuracy and setting out a correct summary of the taxationposition (the "Supplementary Prospectus"). Save as disclosed in the Supplementary Prospectus, there has been no significantnew factor, material mistake or other inaccuracy relating to the informationincluded in the Prospectus. The Supplementary Prospectus has been approved by the UKLA and notified to TheNetherlands Authority for the Financial Markets (Stichting Autoriteit FinancieleMarkten) and will be made available through the Company's website from today atwww.accsysplc.com/investor_governance and through the website of NYSE Euronextat www.euronext.com (in the case of Dutch residents only). . Hard copies of theSupplementary Prospectus and any subsequent supplement to the Prospectus or theSupplementary Prospectus, may be obtained at no cost at either of the followingaddresses:- Accsys Technologies PLC (66 Hammersmith Road, London W14 8UD, United Kingdom). Fortis Bank (Nederland) N.V. (Rokin 55, 1012 KK Amsterdam, tel: +31 20 527 2467,email: prospectus@nl.fortis.com). The availability of the Supplementary Prospectus as from today will also beannounced through advertisements in the Daily Official List (OfficielePrijscourant) and in a Dutch national newspaper (Het Financieele Dagblad). Any investor who has concluded an agreement for the purchase or acquisition ofOffer Shares or who has made an offer aimed at the conclusion of an agreementfor the purchase or acquisition of Offer Shares, has the right to rescind(ontbinden) such agreement or to withdraw (herroepen) such offer, up to andincluding 5.30pm CET on Monday, 17 September 2007. Investors who wish toexercise such rescission or withdrawal rights should send a withdrawal notice,which must include the full name and address of the investor, to Fortis Bank(Nederland) N.V. by facsimile to +31 (0) 2052 71992. For further information, please contact: Accsys Technologies PLC William Paterson-Brown, +44 (0) 20 8144 2510 Chairman & CEO Parkgreen Communications Justine Howarth +44 (0) 20 7851 7480Citigate First Financial B.V. Jose Tijssen +31 (0)20 575 4024 Frank Jansen Other information: This announcement is not an offer to sell or a solicitation of any offer to buythe securities of Accsys Technologies PLC (the "Company", and such securities,the "Securities") in the United States or in any other jurisdiction. The Securities have not been and will not be registered under the U.S.Securities Act of 1933, as amended (the "Securities Act") and may not be offeredor sold in the United States unless registered under the Securities Act or anexemption from such registration is available. No public offering of Securitiesof the Company is being made in the United States. This announcement does not constitute a prospectus. The offer to acquireSecurities pursuant to the proposed offering will be made, and any investorshould make his investment, solely on the basis of information contained in theProspectus (as supplemented by the Supplementary Prospectus) published by theCompany in connection with the Offering and the Euronext Amsterdam Listing.Copies of the Prospectus and the Supplementary Prospectus may be obtained at nocost through the website of Euronext Amsterdam (Dutch residents only) and thewebsite of the Company. All investment is subject to risk. The value of the Securities offered may godown as well as up. Past performance is no guarantee of future returns.Potential investors are advised to seek expert financial advice before makingany investment decision. In connection with the Offering, Fortis Bank (Nederland) N.V. (the "Stabilisation Manager") (or persons acting on behalf of the StabilisationManager) may over-allot shares or effect transactions with a view to supportingthe market price of the Securities at a level higher than that which mightotherwise prevail. However, there is no assurance that the Stabilisation Manager(or persons acting on behalf of the Stabilisation Manager) will undertakestabilisation action. Any stabilisation action may begin on or after the date onwhich adequate public disclosure of the final offer price of the Securities ismade and, if begun, may be ended at any time, but it must end no later than 30days after allotment of the Securities. Certain statements in this announcement are forward-looking statements. Theseforward-looking statements speak only as at the date of this announcement. Suchstatements are based on current expectations and beliefs and, by their nature,are subject to a number of known and unknown risks and uncertainties that couldcause actual results and performance to differ materially from any expectedfuture results or performance expressed or implied by the forward-lookingstatement. The information and opinions expressed in this announcement aresubject to change without notice and neither the Company nor Fortis Bank(Nederland) N.V. assumes any responsibility or obligation to update publicly orreview any of the forward-looking statements contained herein, regardless ofwhether those statements are affected by the results of new information, futureevents or otherwise. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Dec 20237:00 amRNSDirectorate Change
27th Nov 20239:57 amRNSNotifiable Interest - De Engh B.V.
27th Nov 20239:33 amRNSNotifiable Interest – Teslin
24th Nov 202312:21 pmRNSNotifiable Interest – De Engh B.V.
21st Nov 20233:37 pmRNSResults of Capital Raise
21st Nov 20237:04 amRNSHalf-year Report
21st Nov 20237:00 amRNSIssue of Equity
20th Sep 20235:12 pmRNSResults of Annual General Meeting 2023
15th Sep 20233:54 pmRNSNotifiable Interest - De Engh
12th Sep 20237:00 amRNSDirectorate Change
1st Sep 20237:00 amRNSBlock Listing Six Monthly Return
1st Sep 20237:00 amRNSTotal Voting Rights
1st Sep 20237:00 amRNSTrading Update
17th Aug 20235:01 pmRNSNotice of Annual General Meeting 2023
28th Jul 20237:00 amRNSDirector Interests and LTIP Awards
26th Jul 20237:00 amRNSDirectorate Appointment
21st Jul 20233:46 pmRNSAnnual Report and Financial Statements 2023
27th Jun 20237:00 amRNSPreliminary results for the year end 31 March 2023
19th Jun 202312:48 pmRNSChange of Registered Office
6th Jun 20237:00 amRNSDirectorate Update
12th May 202311:21 amRNSBlock Listing Application to AIM
3rd May 20237:00 amRNSTrading Update
4th Apr 20237:00 amRNSCEO Appointment
24th Mar 20237:00 amRNSDirectorate Appointments
2nd Mar 20236:00 pmRNSBlock Listing Six Monthly Return
2nd Mar 20236:00 pmRNSTotal Voting Rights
26th Jan 20237:00 amRNSAccsys Trading Update
15th Dec 20223:55 pmRNSDirector/PDMR Shareholding
12th Dec 20227:00 amRNSDirectorate Change
6th Dec 20223:43 pmRNSNotifiable Interest - De Engh
6th Dec 20223:36 pmRNSNotifiable Interest - Teslin Participaties
22nd Nov 20227:00 amRNSInterim Results for six months ended 30 Sept 2022
17th Nov 20222:58 pmRNSIssue of Equity
10th Nov 20224:37 pmRNSHolding(s) in Company
8th Nov 20225:09 pmRNSHolding(s) in Company
2nd Nov 20227:00 amRNSUpdate on Tricoya – Consortium restructure
1st Nov 20224:12 pmRNSNotice of HY Results and Total Voting Rights
23rd Sep 20224:20 pmRNSResult of AGM
12th Sep 20227:00 amRNSAccsys Trading Update
23rd Aug 20224:49 pmRNSNotice of AGM
23rd Aug 20222:35 pmRNSBlock Listing Application to AIM
3rd Aug 20227:00 amRNSDirectorate Change
27th Jul 20225:56 pmRNSAnnual Report
12th Jul 202210:40 amRNSDirector Interests and LTIP Awards
12th Jul 202210:16 amRNSGrant of Awards under Accsys Deferred Bonus Plan
30th Jun 20227:00 amRNSPreliminary results for the year end 31 March 2022
10th Jun 20227:00 amRNSBoard Changes
1st Jun 20223:42 pmRNSNotifiable Interest – De Engh
1st Jun 20229:50 amRNSNotifiable Interest – Janus Henderson Group Plc
26th May 20222:21 pmRNSDirectors' Interest

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.